In vitro activity of ceftaroline against bacterial isolates causing skin and soft tissue and respiratory tract infections collected in Latin American countries, ATLAS program 2016-2020.
Autor: | Mohamed N; Pfizer, Inc., New York, New York, USA., Valdez RR; Pfizer Latin America, Mexico., Fandiño C; Pfizer Andean Cluster, Santiago, Chile., Baudrit M; Pfizer Central America and Caribbean, San José, Costa Rica., Falci DR; School of Medicine, Pontifical Catholic University of Rio Grande do Sul, RS, Brazil., Murillo JDC; Infectious Diseases Department, Hospital Dr. Rafael Ángel Calderón Guardia, San José, Costa Rica; School of Medicine, Universidad de Costa Rica, San José, Costa Rica. Electronic address: jorge.chaverri@ucr.ac.cr. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2024 Mar; Vol. 36, pp. 4-12. Date of Electronic Publication: 2023 Nov 26. |
DOI: | 10.1016/j.jgar.2023.11.006 |
Abstrakt: | Objectives: Ceftaroline, a broad-spectrum cephalosporin, has activity against Gram-positive and several Gram-negative bacteria (GNB). This study aimed to evaluate the antimicrobial activity of ceftaroline and comparators against isolates causing skin and soft tissue infections (SSTIs) and respiratory tract infections (RTIs) collected in Latin America (LATAM) in 2016-2020 as part of the Antimicrobial Testing Leadership and Surveillance program (ATLAS). Methods: Minimum inhibitory concentrations were determined using both Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. Results: Ceftaroline demonstrated potent activity against methicillin-susceptible Staphylococcus aureus (CLSI/EUCAST: MIC Conclusion: Ceftaroline was active against the recent collection of bacterial pathogens commonly causing SSTIs and RTIs in LATAM. Local and regional surveillance of antimicrobial resistance patterns are crucial to understand evolving resistance and guide treatment management. (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |